Evidence of impaired dabigatran absorption following laparoscopic Roux-en-Y gastric bypass surgery: the Auckland regional experience (2011-2018)

Br J Haematol. 2020 Oct;191(2):e67-e69. doi: 10.1111/bjh.17004. Epub 2020 Jul 28.

Authors

Brian Grainger¹, Rossi Holloway², Eileen Merriman³, Michael Booth², Gordon Royle¹, Richard Babor⁴, Grant Beban², Laura Young⁵

Affiliations

¹ Haematology, Middlemore Hospital, Auckland, New Zealand.
² General Surgery, Auckland City Hospital, Auckland, New Zealand.
³ Haematology, North Shore Hospital, Auckland, New Zealand.
⁴ General Surgery, Middlemore Hospital, Auckland, New Zealand.
⁵ Haematology, Auckland City Hospital, Auckland, New Zealand.

PMID: 32720718
DOI: 10.1111/bjh.17004

No abstract available

Publication types

Clinical Trial, Phase II
Letter
Multicenter Study

MeSH terms

Aged
Aged, 80 and over
Dabigatran / administration & dosage*
Dabigatran / pharmacokinetics*
Diabetes Mellitus, Type 2 / blood*
Diabetes Mellitus, Type 2 / therapy*
Female
Gastric Bypass*
Humans
Laparoscopy*
Male
Middle Aged
New Zealand

Substances

Dabigatran